Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6536
    +0.0013 (+0.19%)
     
  • OIL

    83.75
    +0.18 (+0.22%)
     
  • GOLD

    2,350.00
    +7.50 (+0.32%)
     
  • Bitcoin AUD

    97,836.00
    -1,150.80 (-1.16%)
     
  • CMC Crypto 200

    1,333.04
    -63.49 (-4.55%)
     
  • AUD/EUR

    0.6106
    +0.0033 (+0.55%)
     
  • AUD/NZD

    1.0992
    +0.0035 (+0.31%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,756.36
    +325.86 (+1.87%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • Dow Jones

    38,294.07
    +208.27 (+0.55%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Fertoz's (ASX:FTZ) investors will be pleased with their massive 437% return over the last year

Active investing isn't easy, but for those that do it, the aim is to find the best companies to buy, and to profit handsomely. When you buy and hold the right company, the returns can make a huge difference to both you and your family. In the case of Fertoz Limited (ASX:FTZ), the share price is up an incredible 422% in the last year alone. Also pleasing for shareholders was the 71% gain in the last three months. Also impressive, the stock is up 100% over three years, making long term shareholders happy, too.

So let's assess the underlying fundamentals over the last 1 year and see if they've moved in lock-step with shareholder returns.

See our latest analysis for Fertoz

We don't think Fertoz's revenue of AU$2,255,011 is enough to establish significant demand. So it seems that the investors focused more on what could be, than paying attention to the current revenues (or lack thereof). It seems likely some shareholders believe that Fertoz will find or develop a valuable new mine before too long.

ADVERTISEMENT

Companies that lack both meaningful revenue and profits are usually considered high risk. There is usually a significant chance that they will need more money for business development, putting them at the mercy of capital markets to raise equity. So the share price itself impacts the value of the shares (as it determines the cost of capital). While some such companies go on to make revenue, profits, and generate value, others get hyped up by hopeful naifs before eventually going bankrupt. Fertoz has already given some investors a taste of the sweet gains that high risk investing can generate, if your timing is right.

When it reported in June 2021 Fertoz had minimal cash in excess of all liabilities consider its expenditure: just AU$987k to be specific. So if it has not already moved to replenish reserves, we think the near-term chances of a capital raising event are pretty high. It's a testament to the popularity of the business plan that the share price gained 48% in the last year , despite the weak balance sheet. You can see in the image below, how Fertoz's cash levels have changed over time (click to see the values).

debt-equity-history-analysis
debt-equity-history-analysis

It can be extremely risky to invest in a company that doesn't even have revenue. There's no way to know its value easily. However you can take a look at whether insiders have been buying up shares. It's often positive if so, assuming the buying is sustained and meaningful. Luckily we are in a position to provide you with this free chart of insider buying (and selling).

What about the Total Shareholder Return (TSR)?

We'd be remiss not to mention the difference between Fertoz's total shareholder return (TSR) and its share price return. The TSR attempts to capture the value of dividends (as if they were reinvested) as well as any spin-offs or discounted capital raisings offered to shareholders. Fertoz hasn't been paying dividends, but its TSR of 437% exceeds its share price return of 422%, implying it has either spun-off a business, or raised capital at a discount; thereby providing additional value to shareholders.

A Different Perspective

It's good to see that Fertoz has rewarded shareholders with a total shareholder return of 437% in the last twelve months. Since the one-year TSR is better than the five-year TSR (the latter coming in at 29% per year), it would seem that the stock's performance has improved in recent times. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For instance, we've identified 6 warning signs for Fertoz (1 can't be ignored) that you should be aware of.

Fertoz is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on AU exchanges.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.